Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Carolina, Pellegrini"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/8dd56cd21a3a4f8aa3ef9eadd7730784
Autor:
Elena Lucarini, Laura Benvenuti, Clelia Di Salvo, Vanessa D’Antongiovanni, Carolina Pellegrini, Giulia Valdiserra, Clara Ciampi, Luca Antonioli, Christian Lambiase, Lorenzo Cancelli, Antonio Grosso, Lorenzo Di Cesare Mannelli, Massimo Bellini, Carla Ghelardini, Matteo Fornai
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionVisceral pain represents the most common digestive issue, frequently resulting from long-term inflammation, such as inflammatory bowel diseases. The lack of effective drugs prompted search of new therapeutic approaches. In this regard, ga
Externí odkaz:
https://doaj.org/article/bf1182f9464e427895e057bd023e195d
Autor:
Laura Benvenuti, Clelia Di Salvo, Gabriele Bellini, Luisa Seguella, Francesco Rettura, Giuseppe Esposito, Luca Antonioli, Roberto Ceravolo, Nunzia Bernardini, Carolina Pellegrini, Matteo Fornai
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Parkinson’s disease (PD) is a common and slow-progressing neurodegenerative disorder characterized by motor and non-motor symptoms, including gastrointestinal (GI) dysfunctions. Over the last years, the microbiota-gut-brain (MGB) axis is emerging a
Externí odkaz:
https://doaj.org/article/30f70e78f2724b21a92f14486f03cf72
Autor:
Jessica Grigoletto, Fabiana Miraglia, Laura Benvenuti, Carolina Pellegrini, Sara Soldi, Serena Galletti, Antonino Cattaneo, Emilio Merlo Pich, Maria Grimaldi, Emanuela Colla, Loredana Vesci
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-15 (2023)
Abstract In patients with Parkinson’s disease (PD), constipation is common, and it appears in a prodromal stage before the hallmark motor symptoms. The present study aimed to investigate whether Velusetrag, a selective 5‑HT4 receptor agonist, may
Externí odkaz:
https://doaj.org/article/e033f9b868f44b3b9f1b3b747ced7510
Autor:
Adelaide Panattoni, Marco Calvigioni, Laura Benvenuti, Vanessa D’Antongiovanni, Carolina Pellegrini, Clelia Di Salvo, Diletta Mazzantini, Francesco Celandroni, Matteo Fornai, Luca Antonioli, Emilia Ghelardi
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Microorganisms with probiotic properties are eliciting an increasing interest as coadjuvants in the prevention and treatment of obesity through modulation of the gut microbiota. In this study, a probiotic formulation based on Enterococcus faecium SF6
Externí odkaz:
https://doaj.org/article/1f4f42cf811c4bc48312538af953c684
Autor:
Vanessa D’Antongiovanni, Matteo Fornai, Laura Benvenuti, Clelia Di Salvo, Carolina Pellegrini, Federica Cappelli, Stefano Masi, Luca Antonioli
Publikováno v:
Metabolites, Vol 13, Iss 3, p 410 (2023)
Intestinal epithelial barrier (IEB) impairment and enteric inflammation are involved in the onset of obesity and gut-related dysmotility. Dietary supplementation with natural plant extracts represents a useful strategy for the management of body weig
Externí odkaz:
https://doaj.org/article/ce77130df4ab480d8120fd7e889eb46b
Autor:
Carolina Pellegrini, Vanessa D’Antongiovanni, Matteo Fornai, Emiliano Duranti, Filippo Baldacci, Nunzia Bernardini, Stefano Taddei, Agostino Virdis, Corrado Blandizzi, Stefano Masi, Luca Antonioli
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 6, Pp n/a-n/a (2021)
Abstract Cardiovascular complications in Alzheimer's disease (AD) patients can occur years to decades prior to the onset of clinical symptoms of the disease. Donepezil represents the most effective drug in the treatment of AD. However, the potential
Externí odkaz:
https://doaj.org/article/5529b2c4fc634e7fa64b53eb1fa16397
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/ab29e68187ac49d4ba31f812699968aa
Autor:
Carolina Pellegrini, Vanessa D'Antongiovanni, Chiara Ippolito, Cristina Segnani, Luca Antonioli, Matteo Fornai, Nunzia Bernardini
Publikováno v:
European Journal of Histochemistry, Vol 65, Iss s1 (2021)
Gastrointestinal dysfunctions represent the most common non-motor symptoms in Parkinson’s disease (PD). Of note, changes in gut microbiota, impairments of intestinal epithelial barrier (IEB), bowel inflammation and neuroplastic rearrangements of th
Externí odkaz:
https://doaj.org/article/5722abb7ba724b9a9069a0087edf0e5a
Autor:
Vanessa D’Antongiovanni, Carolina Pellegrini, Luca Antonioli, Laura Benvenuti, Clelia Di Salvo, Lorenzo Flori, Rebecca Piccarducci, Simona Daniele, Alma Martelli, Vincenzo Calderone, Claudia Martini, Matteo Fornai
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Palmitoylethanolamide (PEA), an endogenous lipid mediator, is emerging as a promising pharmacological agent in multiple neurodegenerative disorders for its anti-inflammatory and neuroprotective properties. However, its effects on enteric inflammation
Externí odkaz:
https://doaj.org/article/ed043e7773534734a848874c29ef353a